The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Association between stromal/TGF-β/EMT gene expression signature and response to pembrolizumab monotherapy in cisplatin-ineligible patients with locally advanced (unresectable) or metastatic urothelial carcinoma.
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genentech; Merck; Pfizer; QED Therapeutics; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Daniel E. Castellano
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Janssen; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; Bayer; Ipsen; Janssen; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer; Roche
 
Peter H. O'Donnell
Stock and Other Ownership Interests - Allergan; PrescriptIQ
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Harrison Consulting Group; Inovio Pharmaceuticals; Janssen Biotech; Kantar Health; Merck; OncLive; Parexel; Quintiles; Seagen
Consulting or Advisory Role - Merck
Research Funding - Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Named as co-inventor on a pending patent for a genomic prescribing system for medication prescribing.
Travel, Accommodations, Expenses - Merck; Seattle Genetics/Astellas
Other Relationship - Advance Medical; Janssen
 
Razvan Cristescu
No Relationships to Disclose
 
Tara L. Frenkl
Employment - Amicus Therapeutics (I); Merck
Leadership - Amicus Therapeutics (I)
Stock and Other Ownership Interests - Amicus Therapeutics (I); AstraZeneca; AstraZeneca (I); GlaxoSmithKline; GlaxoSmithKline (I); Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Amicus Therapeutics (I); Merck
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
 
Andrey Loboda
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sandra C. Souza
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Hua Ma
Employment - Merck
 
Alex Snyder
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chunsheng Zhang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrew Albright
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Merck
 
Jared Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Arjun Vasant Balar
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Genentech/Roche; Incyte; Merck; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen